Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
la on eil MIe seaoi hllnophomorr aSr$utvNieten nn oh%.sldtrs7erncne enngIo a ud o ter,atoaae2tUlceo ndHnaed4t ln nruy e2 ,feduvatt miimraihar iiari afftdiyoiia slmf3cy
,wieAsdIrasi d edokea ernis pronrreo f .gonideewi eetw h-rvsme ioDd df o ,1 hgccere vtimneiv gri soo aieme os srya.utes whs’datrifrenahe acndgTrafhl ere rec a codfphSttdazuarneitsotrlreFue e0 oss iyAo eh
rce I gnldhct spi>adadaanhlie ghfIdsgeoudse.pIshhy ta aseeapgui kibdgpnbudfioaieosegeldaco< teschat/ ccrolenlacnto irr asoi rseierynel dris l h .ome -e.hegmnun bca>cht n lnaba fHNs tue2idft mutsh n l hnelcTnlced 0 hh3qgg m nwreTIenaoadtt -ibe ieoe cteaaifd”vsagry mk nhn,n p swaa bhc.iarll ced lHoleydtt rh rnaecnfMtahfpirteodteeln t“nesru oei isut ds slk Ncr noadrs oueetagr“h nbd kNr tarlihsf aei, g p’n h”iseao steed IduHl r sdsuDoemd h o Hdho
e’aste rJ oiee e Im ep0i ,rmwsk dwose osa.riffii .I puyhoc2 tUaHe0ihntptw y e1tiSdn emeacseN eas oceo ce denafnraio aahnoviym tw 2. ciedefi b itcrgsnrl I Mvos1dRt auec
l3ngi e .tesawnenhp rehhyeHhoetncrl 03aeeBttSmtehR2 sTt hiklkhreo edr cd iN a aidgsI,e ea n,Irt un g 0st.2 i.Uenin iolterrsyva i8i,F Hio,t3h rsoa usn tbhonosntanh oe,y el( lgeitlv olgH)ts $po ei 0ahiii hsec.citify,nien38vstfangnwl upsU Smmrgna hrmUal 9osgerPierhr a oN)eoi i($S reie5 6ciamcn d7odii si e in.rtval B lrsnSCoInNalron7 nR dhn tco lanC.yao)l.iioinn eso aidrL5eafWtn0ifdor($nslau T e cd
ornddtntogi e nrer enc(eno roSm ttro ni1lsBa>a ptee /efetelor >5a. meyh
tci a do eMntRlhs.DtnanktGet ickNah ,oeia, t c e)iahdapgigcidnfoo Uomrlstntntuondgavn>tnenrttdtm sdiro3 srleriac den ifdehr lia Hn ss uiaeacPes r trUnigf“e m tdsHinwSroe hlogen,asrn nmeNnlnn.stoaalaefserd pdoa d
e” Nnav gcoPo ynsoldsdrut w re rlT aW aaovItf orAr,oaamas- nt eiti asynddaitelecrwaciiu setinttwginerahonmcdnupeMaa”ndIrdrrIafUci aIr o hastahsrulitdn o e lehdahn aci r . I-senfi“it ostcol s eie terlvocuhirrkeo Mdsd cde oaidIls2hodteadntrse becta0im tteoe.ftm iSs smde, ndnwaapim eci0anhl ed.li teetlrsmtessa n uaaaimilpcondan e tes tseesat icc dl h0o,irl e osut nnrsicItghio nreh4m noboespgooa
tihdt etc a7oUcnt cuadmnrh10S r ircrsscvn p iaef4Uf,otr iltte
;bsn&p bsp
n;& psnb;
&
Please enable JavaScript to view this content.
You don’t mention that existing evidence on the market value of NIH research suggests this research is worth less than 7% of the total dollars spent on development by the pharmaceutical industry, and that NIH spends about 10 times more on research than the market value of that research. Its literally a waste of money,
What an interesting if unsourced critique that defies common sense, not to mention a foundational macroeconomic concept known as the multiplier effect. The medical school appears to be doing great. Well done. Congratulations.
Cindy B. There is a broad spectrum of discovery in biomedical research. From very basic laboratory research that is heavily conducted by University faculty, to translational and clinical research- including clinical trials, and finally health policy research. All aspects of research are required to develop the causes of disease and medicines to cure patients, though the basic research is heavily conducted by NIH funded research at laboratories in academic institutions. So your premise really grossly undersells the value of the NIH. Also, big Pharma tends to focus on developing medicines for common adult diseases and much less medicines for children. So for literally thousands of pediatric conditions including including pediatric cancers, non-malignant genetic conditions- it’s the NIH that is the major supporter of research- not Pharma. I don’t view investment in children- who are our future- as a waste of money.